Lawrence D. Durack

1.7k total citations
19 papers, 1.3k citations indexed

About

Lawrence D. Durack is a scholar working on Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lawrence D. Durack has authored 19 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Radiology, Nuclear Medicine and Imaging, 9 papers in Pathology and Forensic Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lawrence D. Durack's work include Radiopharmaceutical Chemistry and Applications (11 papers), Lymphoma Diagnosis and Treatment (9 papers) and Medical Imaging Techniques and Applications (5 papers). Lawrence D. Durack is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (11 papers), Lymphoma Diagnosis and Treatment (9 papers) and Medical Imaging Techniques and Applications (5 papers). Lawrence D. Durack collaborates with scholars based in United States, South Africa and Sweden. Lawrence D. Durack's co-authors include Janet F. Eary, Oliver W. Press, Irwin D. Bernstein, Dana C. Matthews, Darrell R. Fisher, Frederick R. Appelbaum, David G. Maloney, Stephen H. Petersdorf, Joseph G. Rajendran and Ajay K. Gopal and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Medical Physics.

In The Last Decade

Lawrence D. Durack

19 papers receiving 1.2k citations

Peers

Lawrence D. Durack
Judith Estes United States
Denise Regan United States
Mehmet F. Fer United States
Dave Yamauchi United States
A H Goldstone United Kingdom
Heather Horne United States
Judith Estes United States
Lawrence D. Durack
Citations per year, relative to Lawrence D. Durack Lawrence D. Durack (= 1×) peers Judith Estes

Countries citing papers authored by Lawrence D. Durack

Since Specialization
Citations

This map shows the geographic impact of Lawrence D. Durack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence D. Durack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence D. Durack more than expected).

Fields of papers citing papers by Lawrence D. Durack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence D. Durack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence D. Durack. The network helps show where Lawrence D. Durack may publish in the future.

Co-authorship network of co-authors of Lawrence D. Durack

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence D. Durack. A scholar is included among the top collaborators of Lawrence D. Durack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence D. Durack. Lawrence D. Durack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Nemecek, Eneida R., Damian J. Green, Darrell R. Fisher, et al.. (2008). Extracorporeal Adsorption Therapy: A Method to Improve Targeted Radiation Delivered by Radiometal-Labeled Monoclonal Antibodies. Cancer Biotherapy and Radiopharmaceuticals. 23(2). 181–191. 5 indexed citations
2.
Breitz, Hazel B., Richard E. Wendt, Michael Stabin, et al.. (2006). 166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapy.. PubMed. 47(3). 534–42. 47 indexed citations
3.
Rajendran, Joseph G., Ajay K. Gopal, Lawrence D. Durack, et al.. (2004). Comparison of Radiation Dose Estimation for Myeloablative Radioimmunotherapy for Relapsed or Recurrent Mantle Cell Lymphoma Using 131 I Tositumomab to That of Other Types of Non-Hodgkin's Lymphoma. Cancer Biotherapy and Radiopharmaceuticals. 19(6). 738–745. 3 indexed citations
4.
Rajendran, Joseph G., Darrell R. Fisher, Ajay K. Gopal, et al.. (2004). High-dose (131)I-tositumomab (anti-CD20) radioimmunotherapy for non-Hodgkin's lymphoma: adjusting radiation absorbed dose to actual organ volumes.. PubMed. 45(6). 1059–64. 31 indexed citations
5.
Abrams, Kraig, Sherrill J. Slichter, Peter F. Moore, et al.. (2003). Recombinant human macrophage colony‐stimulating factor‐induced thrombocytopenia in dogs. British Journal of Haematology. 121(4). 614–622. 8 indexed citations
7.
Gopal, Ajay K., Joseph G. Rajendran, Stephen H. Petersdorf, et al.. (2002). High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma. Blood. 99(9). 3158–3162. 151 indexed citations
8.
Press, Oliver W., Janet F. Eary, Ted Gooley, et al.. (2000). A phase I/II trial of iodine-131–tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas. Blood. 96(9). 2934–2942. 210 indexed citations
9.
Matthews, Dana C., Frederick R. Appelbaum, Janet F. Eary, et al.. (1999). Phase I Study of 131I-Anti-CD45 Antibody Plus Cyclophosphamide and Total Body Irradiation for Advanced Acute Leukemia and Myelodysplastic Syndrome. Blood. 94(4). 1237–1247. 215 indexed citations
10.
Matthews, Dana C., Frederick R. Appelbaum, Janet F. Eary, et al.. (1999). Phase I Study of 131I-Anti-CD45 Antibody Plus Cyclophosphamide and Total Body Irradiation for Advanced Acute Leukemia and Myelodysplastic Syndrome. Blood. 94(4). 1237–1247. 11 indexed citations
11.
Eary, JF, Stephen H. Petersdorf, Martin Petřek, et al.. (1998). Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue.. Journal of Clinical Oncology. 16(10). 3270–3278. 219 indexed citations
12.
Eary, Janet F., Kenneth A. Krohn, Oliver W. Press, Lawrence D. Durack, & Irwin D. Bernstein. (1997). Importance of pre-treatment radiation absorbed dose estimation for radioimmunotherapy of non-Hodgkin's lymphoma. Nuclear Medicine and Biology. 24(7). 635–638. 12 indexed citations
13.
Lewellen, T.K., et al.. (1996). Energy-based scatter corrections for scintillation camera images of iodine-131.. PubMed. 37(12). 2030–7. 16 indexed citations
14.
Eary, Janet F., Lawrence D. Durack, Alden N. Bice, et al.. (1994). Post therapy imaging in high dose I‐131 radioimmunotherapy patients. Medical Physics. 21(7). 1157–1162. 13 indexed citations
15.
Bice, Alden N., et al.. (1992). A method for imaging therapeutic doses of iodine-131 with a clinical gamma camera.. PubMed. 33(5). 771–6. 20 indexed citations
16.
Bice, Alden N., et al.. (1991). Assessment of iodine 131 scattering and septal penetration in clinical gamma camera high energy parallel hole collimators. 1058–1059. 7 indexed citations
17.
Eary, Janet F., et al.. (1990). Considerations for Imaging Re-188 and Re-186 Isotopes. Clinical Nuclear Medicine. 15(12). 911–916. 20 indexed citations
18.
Eary, Janet F., Oliver W. Press, Christopher C. Badger, et al.. (1990). Imaging and treatment of B-cell lymphoma.. PubMed. 31(8). 1257–68. 92 indexed citations
19.
Bianco, JA, Brenda M. Sandmaier, C Badger, et al.. (1989). Specific marrow localization of an 131I-labeled anti-myeloid antibody in normal dogs: effects of a "cold" antibody pretreatment dose on marrow localization.. PubMed. 17(9). 929–34. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026